BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 17, 2020
View Archived Issues
Angiopoietin trouble can lead to lymphedema
Read More
Prelude Therapeutics initiates phase I study of PRT-1419
Read More
Enrollment initiates in first-in-human study of ONC-206
Read More
New company Cullinan Florentine to develop bispecific antibody CLN-049 for AML
Read More
Phase I data for coadministered hookworm vaccine candidates, Na-GST-1 and Na-APR-1
Read More
PZ-1818, a dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor
Read More
Arrowhead presents interim phase II data for ARO-AAT in AATD-associated liver disease
Read More
Interim results from ongoing phase Ib/II study of cavrotolimod
Read More
AstraZeneca discloses KRAS mutant inhibitors
Read More
Chaluesheng Medical Technology divulges RET inhibitors
Read More
Chinese researchers present exportin-1 receptor antagonists
Read More
New target identified for ZIKV-induced microcephaly
Read More
Ferro Therapeutics patents new GPX4 inhibitors
Read More
University of California discovers 5-HT2A receptor modulators
Read More
First patient dosed in phase II study of GC-4419 for COVID-19
Read More
New rat model of cortical demyelination reveals benefit of anti-CD20 antibody therapy
Read More
Enrollment ongoing in phase I study of INV-101
Read More
TFF reports topline safety data from phase I study of voriconazole inhalation powder
Read More
DoD grant to support Histogen's evaluation of HST-003 for regeneration of knee cartilage
Read More
INmune receives grant to support phase II testing of XPro-1595 in treatment-resistant depression
Read More
PARP1 inhibitor AG-014699 confers neuroprotection in experimental PD
Read More
AVM receives FDA clearance to study AVM-0703 for COVID-19- and influenza-related ARDS
Read More
Tiziana set to study nasally administered foralumab for treatment of COVID-19
Read More
Immune-Onc begins first-in-human study of IO-202 for AML and CMML
Read More